Morphine Sulfate — Veterinary Vademecum Drug Reference

Dosage & Administration Guidelines

Species	Route	Dose	Frequency	Duration & Clinical Notes
Dog	IV, IM, SC	0.5-2 mg/kg (analgesia); 0.05-0.1 mg/kg (preanesthetic)	q4-6h (analgesia); once (preanesthetic)	Duration: As needed for pain; short-term for anesthesia Notes: IV administration should be slow to avoid histamine release. Lower doses in elderly or debilitated animals.
Cat	IV, IM, SC	0.05-0.2 mg/kg (analgesia); 0.02-0.05 mg/kg (preanesthetic)	q4-6h (analgesia); once (preanesthetic)	Duration: As needed for pain; short-term for anesthesia Notes: Cats are sensitive to morphine; may cause excitement. Use lower doses and monitor closely.
Horse	IV, IM	0.05-0.1 mg/kg (analgesia); 0.02-0.05 mg/kg (sedation in combination)	q4-6h (analgesia); once (sedation)	Duration: As needed for pain; short-term for sedation Notes: May cause excitement in horses; use with tranquilizers (e.g., acepromazine) to reduce excitation.
Cattle	IV, IM, SC	0.05-0.1 mg/kg (analgesia)	q4-6h	Duration: As needed for pain Notes: Use with caution; may cause excitement. Withdrawal times must be observed.
Small Ruminants (Sheep, Goats)	IV, IM, SC	0.05-0.1 mg/kg (analgesia)	q4-6h	Duration: As needed for pain Notes: Use with caution; may cause excitement. Withdrawal times must be observed.
Rabbit	IV, IM, SC	0.5-2 mg/kg (analgesia)	q4-6h	Duration: As needed for pain Notes: Monitor for respiratory depression and GI stasis.
Bird/Poultry	IM	0.5-1 mg/kg (analgesia)	q4-6h	Duration: As needed for pain Notes: Limited data; use with caution.
Exotic/Other	Varies	Species-specific; consult exotic animal formulary	Varies	Duration: As needed Notes: Use with caution; many species are sensitive to opioids.

Clinical Indications & Species Uses

General Indications

Management of acute and chronic severe pain
Preanesthetic sedation
Cough suppression (in dogs)

Dog (Canine)

Analgesia (moderate to severe pain)
Preanesthetic medication
Sedation
Antitussive (less common)

Cat (Feline)

Analgesia (moderate to severe pain)
Preanesthetic medication
Sedation (with caution due to excitement potential)

Horse (Equine)

Analgesia (severe pain, colic)
Sedation (in combination with tranquilizers)

Cattle (Bovine)

Analgesia (severe pain)
Sedation (in combination with tranquilizers)

Small Ruminants (Sheep / Goat)

Analgesia (severe pain)
Sedation (in combination with tranquilizers)

Rabbit & Small Mammals

Analgesia (moderate to severe pain)

Avian & Poultry

Analgesia (moderate to severe pain) - limited data

Exotic & Other Species

Analgesia in various exotic species (e.g., reptiles, small mammals) - use with caution and species-specific dosing

Pharmacology & Mechanism of Action

Drug Class: Opioid Agonist | Pharmacological Group: Phenanthrene Opioid

Mechanism of Action: Morphine is a pure opioid agonist that primarily acts on mu-opioid receptors in the central nervous system (CNS) and periphery. It mimics endogenous endorphins and enkephalins, leading to G-protein coupled receptor activation, inhibition of adenylate cyclase, decreased cAMP production, and modulation of ion channels (increased potassium efflux, decreased calcium influx). This results in reduced neurotransmitter release (e.g., substance P, glutamate) and inhibition of ascending pain pathways, producing analgesia, sedation, euphoria, and antitussive effects. It also activates mu-receptors in the brainstem to suppress cough and respiratory centers, and in the gastrointestinal tract to reduce motility and secretions.

Pharmacodynamics: Morphine produces dose-dependent analgesia, sedation, and euphoria. It also causes respiratory depression, cough suppression, miosis (in dogs and humans; mydriasis in cats), bradycardia (except in horses where tachycardia may occur), and gastrointestinal effects such as reduced motility and constipation. It can cause histamine release leading to vasodilation, hypotension, and pruritus. In dogs, it may cause panting and salivation; in cats, it may cause excitement and hyperthermia at high doses. It has a ceiling effect on analgesia but not on respiratory depression.

⚡ Pharmacokinetics Summary

Absorption: Morphine is well absorbed after oral administration but undergoes extensive first-pass metabolism, resulting in low oral bioavailability (about 20-30% in dogs). Parenteral routes (IV, IM, SC) provide rapid absorption. Rectal absorption is variable. In horses, oral absorption is poor and erratic.

Distribution: Morphine is widely distributed throughout the body, with high concentrations in the kidneys, liver, lungs, and spleen. It crosses the blood-brain barrier and placenta. Volume of distribution is approximately 1-6 L/kg depending on species. Protein binding is low (about 20-35%).

Metabolism: Morphine is primarily metabolized in the liver via glucuronidation to morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G). M6G is an active metabolite with analgesic properties. In cats, glucuronidation is deficient, leading to slower metabolism and prolonged effects. In horses, metabolism is also hepatic but may involve different pathways.

Excretion: Excretion is primarily renal, with metabolites and some unchanged drug excreted in urine. Biliary excretion also occurs with enterohepatic recirculation. In dogs, about 75% of a dose is excreted in urine within 24 hours. In cats, excretion is slower due to reduced metabolism.

Half-Life: Dog: 1-2 hours (IV); Cat: 1-3 hours (IV); Horse: 1-2 hours (IV); Cattle: 1-2 hours (IV); Rabbit: 1-2 hours (IV).

Bioavailability: Oral: 20-30% in dogs; IM/SC: nearly 100%; Rectal: variable, about 50% in dogs.

Protein Binding: Approximately 20-35% in most species.

Available Formulations & Strengths

Injectable Solution 10 mg/mL, 15 mg/mL, 50 mg/mL (IV, IM, SC)

Oral Tablet 15 mg, 30 mg (PO)

Oral Solution 10 mg/5 mL, 20 mg/5 mL (PO)

Extended-Release Tablet 15 mg, 30 mg, 60 mg (PO)

Suppository 5 mg, 10 mg, 20 mg (Rectal)

Contraindications & Clinical Warnings

Contraindications:

Hypersensitivity to morphine or other opioids
Severe respiratory depression or acute asthma
Head trauma or increased intracranial pressure
Gastrointestinal obstruction or ileus
Concurrent use of MAO inhibitors (within 14 days)
Severe hepatic or renal insufficiency (use with caution)
Hypoadrenocorticism (Addison's disease)
Premature or very young animals (respiratory depression risk)
In horses: severe colic with impaction (may worsen ileus)

Warnings & Clinical Precautions:

Use with caution in animals with respiratory compromise, bradyarrhythmias, hypotension, or shock.
May cause histamine release; administer slowly IV and consider pretreatment with antihistamines in dogs.
In cats, may cause excitement and hyperthermia; use lower doses and monitor.
In horses, may cause excitation and increased locomotor activity; use with tranquilizers.
Prolonged use may lead to physical dependence and withdrawal symptoms upon abrupt cessation.
Use with caution in geriatric or debilitated animals; reduce dose.
Monitor for constipation and urinary retention.
In food animals, observe withdrawal times.
Avoid in animals with known seizure disorders (may lower seizure threshold).
Use with caution in animals with hypothyroidism or adrenal insufficiency.

Adverse Effects & Reactions

Common:

Sedation
Respiratory depression
Bradycardia
Hypotension
Miosis (dogs)
Mydriasis (cats)
Panting (dogs)
Salivation
Vomiting
Constipation
Urinary retention
Pruritus (due to histamine release)

Serious / Severe:

Severe respiratory depression
Cardiovascular collapse
Excitement or delirium (especially in cats and horses)
Hyperthermia (cats)
Ileus or gastrointestinal stasis
Seizures (rare)
Anaphylactoid reactions (due to histamine release)

Rare:

Hypothermia
Paradoxical agitation
Muscle rigidity
Allergic reactions
Hepatotoxicity (with high doses)

Key Drug Interactions

Interacting Drug / Class	Clinical Effect & Mechanism	Severity
Other CNS depressants (barbiturates, benzodiazepines, phenothiazines, anesthetics)	Additive CNS and respiratory depression	High
MAO inhibitors (e.g., selegiline)	Risk of serotonin syndrome or hypertensive crisis	High
Tricyclic antidepressants (e.g., amitriptyline)	Increased sedation and anticholinergic effects	Moderate
Anticholinergics (e.g., atropine)	Increased risk of ileus and urinary retention	Moderate
Muscle relaxants (e.g., methocarbamol)	Enhanced muscle relaxation and sedation	Moderate
Beta-blockers (e.g., propranolol)	Potential for additive bradycardia	Moderate
Cimetidine	May increase morphine levels by inhibiting metabolism	Mild
Rifampin	May decrease morphine efficacy by inducing metabolism	Mild

Overdose & Toxicity Management

Signs of Toxicity:

Severe respiratory depression (bradypnea, apnea)
Cyanosis
Hypotension
Bradycardia
Hypothermia
Miosis (dogs) or mydriasis (cats)
Coma
Muscle flaccidity
Pulmonary edema (rare)
Seizures (in cats)

Emergency Treatment Protocol: Maintain airway and provide respiratory support (mechanical ventilation if needed). Administer naloxone (opioid antagonist) at 0.01-0.04 mg/kg IV, IM, SC; may repeat as needed. Monitor for withdrawal signs (excitement, tachycardia, hypertension) and treat symptomatically. Supportive care: fluids for hypotension, temperature regulation, and monitoring of vital signs. In severe cases, consider activated charcoal if oral ingestion within 1-2 hours.

Food Animal Withdrawal Times

🥩 Meat: 7 days🥛 Milk: 3 days

Withdrawal times are not officially established for morphine in food animals; use extra-label with caution and consult regulatory guidelines. The values provided are general estimates based on pharmacokinetic data; actual withdrawal times may vary. In the US, morphine is not approved for food animals, so extra-label use requires a valid VCPR and extended withdrawal times.

Storage, Handling & Regulatory Information

Storage Temperature: 15-30°C (59-86°F)

Light Sensitivity: Light-sensitive — protect from direct exposure.

Handling & Special Conditions: Protect from light. Store in a tightly closed container. Do not freeze. Keep out of reach of children and animals. Controlled substance storage requirements apply.

Dispensing Status: Prescription Required (Rx Only)

Approval Status: Approved for use in dogs and cats (injectable) for analgesia and preanesthetic; not approved for food animals. Some formulations are approved for human use but used extra-label in veterinary medicine.

Extra-Label (Off-Label) Use: In the US, extra-label use of morphine in food animals is prohibited or requires extended withdrawal times under AMDUCA. It is a Schedule II controlled substance, so strict record-keeping and security are required. In the EU, similar regulations apply under veterinary medicines legislation.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Morphine is a potent opioid analgesic used for managing moderate to severe pain in veterinary patients. It is particularly useful for perioperative pain, trauma, and cancer pain. Due to its potential for respiratory depression and histamine release, careful dosing and monitoring are essential. In dogs, morphine is often preferred over other opioids for its reliable analgesic effect, but it can cause panting and vomiting. In cats, morphine is less commonly used due to the risk of excitement and hyperthermia; other opioids like buprenorphine or fentanyl are often preferred. In horses, morphine is used for severe colic pain but must be combined with sedatives to prevent excitation. For food animals, morphine is rarely used due to withdrawal times and regulatory restrictions. Always consider the individual patient's health status, concurrent medications, and the potential for abuse. Naloxone should be readily available in case of overdose. For chronic pain, consider multimodal analgesia and alternative opioids with better safety profiles.

References & Literature

📚 Plumb's Veterinary Drug Handbook
📚 Papich Veterinary Pharmacology and Therapeutics
📚 Compendium of Veterinary Products (CVP)